Sopan Pharmaceuticals IPO Allotment Finalized | Check your IPO result
Sopan Pharmaceuticals Limited recently concluded its Initial Public Offering (IPO) for the general public. This IPO got significant interest from investors across Nepal. Following its successful offering to foreign migrated workers in late March, the company opened its doors to local retail investors from April 16 to April 21, 2026 (Baishakh 3 to Baishakh 8, 2083).
IPO Overview
The company issued a total of 4,290,000 units of ordinary shares, representing 25% of its issued capital. For the general public phase, 3,474,900 units were made available after accounting for reservations for employees (171,600 units) and mutual funds (214,500 units).
Given the current market enthusiasm, the issue was expected to be oversubscribed. Under the prevailing SEBI guidelines in Nepal, if an IPO is oversubscribed, the allotment is typically conducted through a lottery system where lucky applicants are awarded 10 units each.
Ways to Check Your Allotment Status
There are mainly three steps to check the allotment status:
- CDSC IPO Result Portal: This is the fastest method. Visit iporesult.cdsc.com.np, select “Sopan Pharmaceuticals Limited” from the dropdown menu, and enter your 16-digit BOID number.
- MeroShare: Log in to your MeroShare account, navigate to the “My ASBA” section, and click on “Application Report.” Your status will be listed as “Allotted” or “Not Allotted”.
- Issue Manager Website: You can check the allotment of Sopan Pharmaceuticals at the website of Sopan Pharmaceuticals.
About Sopan Pharmaceuticals
Sopan Pharmaceuticals is a WHO-GMP and ISO-certified company based in Lalitpur. It produces a wide range of generic and cephalosporin drugs. This company is holding licenses for over 139 types of medications. While CARE Ratings Nepal give the this company ‘CARE-NP B’ rating. This rating indicates high risk—the company’s expansion into the public market marks a significant milestone in its growth strategy. At the corporate office of NMB capital the allotment programme is happened
Sopan Pharmaceuticals IPO Summary
| Feature | Details |
|---|---|
| Total Units Issued (Public) | 4,290,000 units |
| Units for General Public | 3,474,900 units |
| Face Value per Share | Rs. 100 |
| Opening Date | Baishakh 3, 2083 (April 16, 2026) |
| Closing Date (Earliest) | Baishakh 8, 2083 (April 21, 2026) |
| Closing Date (Latest) | Baishakh 17, 2083 (April 30, 2026) |
| Minimum Application | 10 units (Rs. 1,000) |
| Maximum Application | 11,000 units |
| Issue Manager | NMB Capital Limited |
| Credit Rating | CARE-NP B (Single B) – High Risk |
From Editor : If you want to promote your content at our website. Please whattsapp at 9803796816